Partnership reflects a bigger shift: medical wearables are becoming part of healthcare’s infrastructure, not just another device on the wrist.
Modern hospitals have monitors, alarms, dashboards and devices constantly generating new readings, so no shortage of information. Yet one of healthcare’s biggest challenges isn’t collecting more data, but making sense of it.
Too many alerts can overwhelm clinicians rather than help them. The phenomenon has a name: “alarm fatigue.” When every beep demands attention, distinguishing a genuine emergency from background noise becomes increasingly difficult. Add ongoing nursing shortages and rising patient numbers, and the pressure only intensifies.
The next frontier may not be building another wearable, but building systems that make wearable data genuinely useful. That is the backdrop to Medtronic’s latest announcement. The healthcare technology giant has expanded its Acute Care & Monitoring portfolio in the US through an exclusive distribution agreement with Dutch medtech company Corsano Health, bringing its FDA-cleared Corsano multi-parameter wearable to hospitals and hospital-to-home care across the country [1].
Consumer wearables have spent the past decade encouraging healthier lifestyles by tracking sleep, exercise and heart rate. Increasingly, the same wrist-worn format is finding a place in our hospitals.
Rather than developing its own wearable, Medtronic has chosen to integrate Corsano’s medical-grade device into its HealthCast patient monitoring platform. The wearable continuously tracks several vital signs – including heart rate, blood oxygen levels, skin temperature and activity – while also measuring respiratory rate at intervals, allowing clinicians to monitor patients both inside the hospital and during recovery at home.
The agreement follows the device’s launch in Western Europe in 2025, extending its reach into the US healthcare system.
“The Corsano multi-parameter wearable meaningfully expands our US portfolio of wearable patient monitoring solutions, helping to protect more patients in more settings,” said Kate Benedict, president of Medtronic’s Acute Care & Monitoring business.
She added that the wearable has already supported care across European emergency departments, surgical units and cardiac care settings, following patients from pre-operative assessment through hospital recovery and back home.
An interesting aspect of the announcement is what Medtronic didn’t do. The company didn’t build another smartwatch or acquire a high-profile consumer wearable brand. Instead, it partnered with a company that already specializes in clinical monitoring and plugged that device into its existing digital ecosystem. Competitive advantage isn’t just about owning the device, but about owning the platform that connects patients, clinicians and data.
As healthcare investor Leonard Rinser observed after the announcement in a LinkedIn post, “When a company like Medtronic puts a wearable on its own platform, ‘wearable’ stops being a consumer category and starts becoming clinical infrastructure [2].” It’s a subtle but important distinction. The wearable becomes less of a gadget and more of another node in the healthcare network.
Of course, collecting more information doesn’t automatically improve care. The announcement sparked discussion among clinicians who welcomed the direction of travel while highlighting an important caveat: continuous monitoring only creates value if the information is reliable, actionable and fits naturally into clinical workflows.
Physician Dr Felix Karsten argued in his comment that the real challenge isn’t measuring more parameters but making wearable data trustworthy and clinically meaningful through context-aware alerts, clear escalation pathways and seamless integration into everyday practice [2].
Others questioned whether continuous monitoring always offers an advantage. Healthcare executives noted that wearables can still face challenges with measurement accuracy under certain conditions and warned that excessive alerts risk contributing to the very alarm fatigue hospitals are trying to reduce.
These aren’t arguments against medical wearables; they’re reminders that technology alone rarely solves healthcare’s biggest problems. Better care depends on better interpretation.
For the longevity sector, Medtronic’s latest move is about far more than a new wristband. Longevity has long championed a future where healthcare becomes proactive rather than reactive – where subtle physiological changes are detected before they develop into medical crises. Continuous monitoring is an important piece of that vision, but only if the data can be transformed into timely, meaningful clinical insight.
Today’s medical wearables are already extending monitoring beyond hospital walls. Tomorrow’s challenge will be helping clinicians identify which signals deserve immediate attention and which can safely remain in the background. As AI and predictive analytics continue to mature, the ambition is no longer simply to record what is happening in real time, but to recognize patterns that may indicate deterioration before symptoms become obvious.
Whether that future helps reduce alarm fatigue, eases pressure on overstretched healthcare teams or enables earlier intervention will depend on more than sensors alone. It will depend on how intelligently healthcare systems connect data, people and clinical decision-making. That is what makes Medtronic’s partnership with Corsano more than another wearable announcement. It offers a glimpse of healthcare’s next chapter where the value isn’t measured by how much data we collect, but by how effectively we use it to keep people healthier for longer.
[1] https://news.medtronic.com/Medtronic-expands-its-Acute-Care-Monitoring-wearables-portfolio-in-the-U-S-with-a-new-distribution-agreement-for-the-Corsano-TM-multi-parameter-wearable
[2] https://www.linkedin.com/posts/leonardrinser_medtronic-one-of-the-worlds-largest-medtech-activity-7477971859024781312-Gxi7
